Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Safia H E Cheeney

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pediatric Radiology|August 8, 2022
Safety considerations related to intravenous contrast agents in pediatric imagingSafia H E Cheeney, Ezekiel Maloney, Ramesh S Iyer
Pediatric Radiology|April 27, 2021
Pediatric hyperparathyroidism: review and imaging updateHedieh Khalatbari, Safia H E Cheeney, Scott C Manning, et al.
Pediatric Radiology|November 3, 2022
Meckel diverticulum scintigraphy: technique, findings and diagnostic pitfallsHassan A Aboughalia, Safia H E Cheeney, Saeed Elojeimy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid TumorsNavin Pinto, Catherine M Albert, Mallory R Taylor, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pediatric Radiology|August 8, 2022
Safety considerations related to intravenous contrast agents in pediatric imagingSafia H E Cheeney, Ezekiel Maloney, Ramesh S Iyer
Pediatric Radiology|April 27, 2021
Pediatric hyperparathyroidism: review and imaging updateHedieh Khalatbari, Safia H E Cheeney, Scott C Manning, et al.
Pediatric Radiology|November 3, 2022
Meckel diverticulum scintigraphy: technique, findings and diagnostic pitfallsHassan A Aboughalia, Safia H E Cheeney, Saeed Elojeimy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid TumorsNavin Pinto, Catherine M Albert, Mallory R Taylor, et al.
Pageof 1